Wednesday, May 18, 2022 CLC3E sub-study titled: An Economic Analysis of Early VS Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Companion Analysis to CCTG CLC.3 / SWOG 1925 Randomized Phase 3 Clinical Trial has been centrally activated. For more information please visit the CCTG CLC3 trial page
